Revolution Medicines to acquire biopharmaceutical company EQRx

Revolution Medicines has signed a definitive agreement to acquire biopharmaceutical company EQRx in an all-stock transaction.

Aug 2, 2023 - 20:00

Revolution Medicines to acquire biopharmaceutical company EQRx

Revolution Medicines has signed a definitive agreement to acquire biopharmaceutical company EQRx in an all-stock transaction.

Read the original article

Tags:

Previous Article

UBC to bolster safety functions with Oracle’s cloud technology

Quest Diagnostics Launches Blood Test for Alzheimer’s Disease Aimed at General C...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

EC grants approval to Merck’s Keytruda for gastric cancer

EC grants approval to Merck’s Keytruda for gastric cancer

Aug 30, 2023

CDC to cut back on Covid data it collects as public health emergency ends

CDC to cut back on Covid data it collects as public hea...

May 5, 2023

Multiply Labs and GenScript partner on cell isolation automation

Multiply Labs and GenScript partner on cell isolation a...

Apr 27, 2024